A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer: Big Ten Cancer Research Consortium. BTCRC-LUN17-127

Learn more:

• https://clinicaltrials.gov/study/NCT03575793
• See Study Locations on Big Ten CRC Website